Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
7719 | 1257 | 36.2 | 72% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1258 | 8423 | PHAGE DISPLAY//CATALYTIC ANTIBODIES//CATALYTIC ANTIBODY |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CATALYTIC ANTIBODY | Author keyword | 179 | 74% | 11% | 132 |
2 | CATALYTIC ANTIBODIES | Author keyword | 165 | 71% | 11% | 134 |
3 | ABZYMES | Author keyword | 93 | 88% | 4% | 44 |
4 | ABZYME | Author keyword | 82 | 82% | 4% | 47 |
5 | CHEM IMMUNOL THER EUT | Address | 32 | 85% | 1% | 17 |
6 | ANTIBODY CATALYSIS | Author keyword | 26 | 100% | 1% | 11 |
7 | HUMAN BLOOD ANTIBODIES | Author keyword | 20 | 100% | 1% | 9 |
8 | NATURAL ABZYMES | Author keyword | 17 | 100% | 1% | 8 |
9 | CATALYTIC IGG | Author keyword | 14 | 100% | 1% | 7 |
10 | MINIST PUBL HLTH RUSSIAN FEDERAT | Address | 13 | 69% | 1% | 11 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CATALYTIC ANTIBODY | 179 | 74% | 11% | 132 | Search CATALYTIC+ANTIBODY | Search CATALYTIC+ANTIBODY |
2 | CATALYTIC ANTIBODIES | 165 | 71% | 11% | 134 | Search CATALYTIC+ANTIBODIES | Search CATALYTIC+ANTIBODIES |
3 | ABZYMES | 93 | 88% | 4% | 44 | Search ABZYMES | Search ABZYMES |
4 | ABZYME | 82 | 82% | 4% | 47 | Search ABZYME | Search ABZYME |
5 | ANTIBODY CATALYSIS | 26 | 100% | 1% | 11 | Search ANTIBODY+CATALYSIS | Search ANTIBODY+CATALYSIS |
6 | HUMAN BLOOD ANTIBODIES | 20 | 100% | 1% | 9 | Search HUMAN+BLOOD+ANTIBODIES | Search HUMAN+BLOOD+ANTIBODIES |
7 | NATURAL ABZYMES | 17 | 100% | 1% | 8 | Search NATURAL+ABZYMES | Search NATURAL+ABZYMES |
8 | CATALYTIC IGG | 14 | 100% | 1% | 7 | Search CATALYTIC+IGG | Search CATALYTIC+IGG |
9 | REACTIVE IMMUNIZATION | 12 | 86% | 0% | 6 | Search REACTIVE+IMMUNIZATION | Search REACTIVE+IMMUNIZATION |
10 | HYDROLYSIS OF MYELIN BASIC PROTEIN | 11 | 100% | 0% | 6 | Search HYDROLYSIS+OF+MYELIN+BASIC+PROTEIN | Search HYDROLYSIS+OF+MYELIN+BASIC+PROTEIN |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CATALYTIC ANTIBODIES | 146 | 50% | 17% | 208 |
2 | HEALTHY HUMAN MOTHERS | 128 | 94% | 4% | 46 |
3 | PROTEOLYTIC ANTIBODIES | 85 | 100% | 2% | 26 |
4 | HYDROLYZING ANTIBODIES | 37 | 100% | 1% | 14 |
5 | AMYLOLYTIC ACTIVITY | 35 | 74% | 2% | 26 |
6 | ABZYME | 35 | 81% | 2% | 21 |
7 | DNA HYDROLYZING AUTOANTIBODIES | 26 | 100% | 1% | 11 |
8 | ADAPTER IMMUNOTHERAPY | 25 | 73% | 2% | 19 |
9 | POLYREACTIVE CATALYTIC ANTIBODIES | 24 | 91% | 1% | 10 |
10 | RNA HYDROLYZING ANTIBODIES | 24 | 91% | 1% | 10 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Critical analysis of antibody catalysis | 2000 | 154 | 179 | 53% |
FROM MOLECULAR DIVERSITY TO CATALYSIS - LESSONS FROM THE IMMUNE-SYSTEM | 1995 | 315 | 89 | 69% |
Catalytic antibodies as designer proteases and esterases | 2002 | 49 | 117 | 83% |
Catalytic antibodies in healthy humans and patients with autoimmune and viral diseases | 2003 | 61 | 38 | 84% |
Binding energy and catalysis: The implications for transition-state analogs and catalytic antibodies | 1997 | 219 | 113 | 55% |
Antibody-mediated catalysis: Induction and therapeutic relevance | 2013 | 5 | 55 | 85% |
Chemically programmed antibodies | 2014 | 6 | 79 | 33% |
Autoantibodies with enzymatic properties in human autoimmune diseases | 2011 | 14 | 67 | 49% |
Catalytic antibodies: hapten design strategies and screening methods | 2004 | 33 | 97 | 80% |
The chemistry of the antibody molecule | 2002 | 44 | 49 | 57% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CHEM IMMUNOL THER EUT | 32 | 85% | 1.4% | 17 |
2 | MINIST PUBL HLTH RUSSIAN FEDERAT | 13 | 69% | 0.9% | 11 |
3 | LIFE SCI BIOMOL ENGN | 12 | 59% | 1.0% | 13 |
4 | STRUCT MECHANIST ENZYMOL | 8 | 62% | 0.6% | 8 |
5 | UNITE MIXTE RECH 6022 | 6 | 100% | 0.3% | 4 |
6 | CHEM IMMUNOL | 5 | 20% | 1.9% | 24 |
7 | REPAIR ENZYMES | 2 | 44% | 0.3% | 4 |
8 | CHIM BIORGAN BIOINORGAN | 2 | 67% | 0.2% | 2 |
9 | MOL ENZYMOL ENGN EDUC MINIST | 2 | 67% | 0.2% | 2 |
10 | PHD PH2D | 2 | 67% | 0.2% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000120613 | CANONICAL STRUCTURES//CDR CONFORMATION//ANTIBODY STRUCTURE |
2 | 0.0000100940 | IMMUNOPHARMACOTHERAPY//COCAINE HYDROLASE//NICOTINE VACCINE |
3 | 0.0000071368 | ARTIFICIAL METALLOENZYMES//ARTIFICIAL METALLOENZYME//HIGH INTENS XRAY DIFFRACT |
4 | 0.0000054509 | MULTIMERIC LIGANDS//NDP ALPHA MSH//DISSOCIATION ENHANCED LANTHANIDE FLUOROIMMUNOASSAY |
5 | 0.0000053489 | SCFV//SINGLE CHAIN FV//PHAGE DISPLAY |
6 | 0.0000053147 | DIRECTED EVOLUTION//DNA SHUFFLING//EPPCR |
7 | 0.0000050500 | COMPUTATIONAL PROTEIN DESIGN//DEAD END ELIMINATION//COMPUTATIONAL ENZYME DESIGN |
8 | 0.0000045150 | NUTR SAFETY FOOD//ANIM NUTR METAB DIS TOXICOPATHY//ANTI CD EDTA ANTIBODY |
9 | 0.0000043657 | ODCASE//OROTIDINE 5 MONOPHOSPHATE DECARBOXYLASE//MOL DESIGN PREFORMULAT |
10 | 0.0000043539 | TWO JET PLASMA//FLUORIDE VOLATILITY METHOD//POTASSIUM TETRAFLUOROBROMATE |